BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 18572475)

  • 21. FDA notifications. FDA approves generic lamivudine.
    AIDS Alert; 2008 Dec; 23(12):142. PubMed ID: 19110688
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA notifications. FDA tentatively approves generic lamivudine.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580368
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA approves tenofovir.
    AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892608
    [No Abstract]   [Full Text] [Related]  

  • 24. Tenofovir: Gilead applies for approval; expanded access liberalized.
    Gilden D
    AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA notifications. FDA approves generic combination of efavirenz, lamivudine & tenofovir.
    AIDS Alert; 2009 Nov; 24(11):130. PubMed ID: 19960612
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA notifications. Complera approved.
    AIDS Alert; 2011 Nov; 26(11):130-1. PubMed ID: 22164521
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA notifications. Tentative approval for generic stavudine, oral solution.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415959
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA approves three generics.
    AIDS Patient Care STDS; 2009 Apr; 23(4):305. PubMed ID: 19358692
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA notifications. Generic stavudine and efavirenz are tentatively approved by FDA.
    AIDS Alert; 2008 Apr; 23(4):46. PubMed ID: 19253455
    [No Abstract]   [Full Text] [Related]  

  • 30. Tenofovir DF expanded access. Criteria for U.S. program.
    AIDS Treat News; 2001 Feb; (360):2-3. PubMed ID: 12173565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gilead sciences releases Viread.
    Giles C
    Surviv News (Atlanta Ga); 2002 Jan; ():15. PubMed ID: 11870987
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA notifications. FDA tentatively approves fixed-dose lamivudine/zidovudine.
    AIDS Alert; 2010 Dec; 25(12):142-3. PubMed ID: 21328815
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA notifications. FDA grants tentative approval to generic stavudine.
    AIDS Alert; 2006 Feb; 21(2):24. PubMed ID: 16562341
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA notifications. FDA grants tentative approval to generic Nevirapine.
    AIDS Alert; 2006 Feb; 21(2):23-4. PubMed ID: 16562340
    [No Abstract]   [Full Text] [Related]  

  • 36. Generic stavudine approved.
    AIDS Patient Care STDS; 2009 May; 23(5):396-7. PubMed ID: 19422067
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA notifications. Tentative approval for lamivudine.
    AIDS Alert; 2009 Aug; 24(8):93-4. PubMed ID: 19708084
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA notifications. Combination lamivudine and tenofovir tablet approved.
    AIDS Alert; 2010 Jan; 25(1):10. PubMed ID: 20140989
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA notifications. FDA grants approval for generic didanosine for oral solution.
    AIDS Alert; 2007 May; 22(5):58-9. PubMed ID: 17577960
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA notifications. Generic lamivudine tentatively approved.
    AIDS Alert; 2005 Dec; 20(12):142. PubMed ID: 16400721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.